These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34369627)

  • 1. Increasing plasma glucose before the development of type 1 diabetes-the TRIGR study.
    Ludvigsson J; Cuthbertson D; Becker DJ; Kordonouri O; Aschemeier B; Pacaud D; Clarson C; Krischer JP; Knip M;
    Pediatr Diabetes; 2021 Nov; 22(7):974-981. PubMed ID: 34369627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes.
    Pacaud D; Nucci AM; Cuthbertson D; Becker DJ; Virtanen SM; Ludvigsson J; Ilonen J; Knip M;
    Diabetologia; 2021 Jan; 64(1):119-128. PubMed ID: 33026463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Stene LC; Barriga K; Hoffman M; Kean J; Klingensmith G; Norris JM; Erlich HA; Eisenbarth GS; Rewers M
    Pediatr Diabetes; 2006 Oct; 7(5):247-53. PubMed ID: 17054445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA.
    Martinez MM; Salami F; Larsson HE; Toppari J; Lernmark Å; Kero J; Veijola R; Koskenniemi JJ; Tossavainen P; Lundgren M; Borg H; Katsarou A; Maziarz M; Törn C;
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00198. PubMed ID: 33855205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study.
    Carlsson A; Shepherd M; Ellard S; Weedon M; Lernmark Å; Forsander G; Colclough K; Brahimi Q; Valtonen-Andre C; Ivarsson SA; Elding Larsson H; Samuelsson U; Örtqvist E; Groop L; Ludvigsson J; Marcus C; Hattersley AT
    Diabetes Care; 2020 Jan; 43(1):82-89. PubMed ID: 31704690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA1c Predicts Time to Diagnosis of Type 1 Diabetes in Children at Risk.
    Helminen O; Aspholm S; Pokka T; Hautakangas MR; Haatanen N; Lempainen J; Ilonen J; Simell O; Knip M; Veijola R
    Diabetes; 2015 May; 64(5):1719-27. PubMed ID: 25524912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher prevalence of autoantibodies to insulin and GAD65 in Swedish compared to Lithuanian children with type 1 diabetes.
    Holmberg H; Vaarala O; Sadauskaite-Kuehne V; Ilonen J; Padaiga Z; Ludvigsson J
    Diabetes Res Clin Pract; 2006 Jun; 72(3):308-14. PubMed ID: 16442659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort.
    Kordonouri O; Cuthbertson D; Belteky M; Aschemeier-Fuchs B; White NH; Cummings E; Knip M; Ludvigsson J
    Diabetologia; 2022 Dec; 65(12):2098-2107. PubMed ID: 36083343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
    Andersson C; Carlsson A; Cilio C; Cedervall E; Ivarsson SA; Jonsdottir B; Jönsson B; Larsson K; Neiderud J; Lernmark A; Elding Larsson H;
    Pediatr Diabetes; 2013 Aug; 14(5):341-9. PubMed ID: 23469940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests.
    Vehik K; Boulware D; Killian M; Rewers M; McIndoe R; Toppari J; Lernmark Å; Akolkar B; Ziegler AG; Rodriguez H; Schatz DA; Krischer JP; Hagopian W;
    Diabetes Care; 2022 Oct; 45(10):2342-2349. PubMed ID: 36150054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
    Lundberg TP; Højlund K; Snogdal LS; Jensen DM
    Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
    Lorini R; Alibrandi A; Vitali L; Klersy C; Martinetti M; Betterle C; d'Annunzio G; Bonifacio E;
    Diabetes Care; 2001 Jul; 24(7):1210-6. PubMed ID: 11423504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant medication use and trajectories of fasting plasma glucose, glycated haemoglobin, β-cell function and insulin sensitivity: a 9-year longitudinal study of the D.E.S.I.R. cohort.
    Azevedo Da Silva M; Dugravot A; Balkau B; Roussel R; Fumeron F; Elbaz A; Canonico M; Singh-Manoux A; Nabi H;
    Int J Epidemiol; 2015 Dec; 44(6):1927-40. PubMed ID: 26245205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between HbA
    Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M
    Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced β-cell function in early preclinical type 1 diabetes.
    Koskinen MK; Helminen O; Matomäki J; Aspholm S; Mykkänen J; Mäkinen M; Simell V; Vähä-Mäkilä M; Simell T; Ilonen J; Knip M; Veijola R; Toppari J; Simell O
    Eur J Endocrinol; 2016 Mar; 174(3):251-9. PubMed ID: 26620391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).
    Knip M; Virtanen SM; Becker D; Dupré J; Krischer JP; Åkerblom HK;
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1814S-1820S. PubMed ID: 21653795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk.
    Parikka V; Näntö-Salonen K; Saarinen M; Simell T; Ilonen J; Hyöty H; Veijola R; Knip M; Simell O
    Diabetologia; 2012 Jul; 55(7):1926-36. PubMed ID: 22441569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.